Clavispora lusitaniae and chaetomium atrobrunneum as rare agents of cutaneous infection

Mycopathologia

Volumn 169, Issue 5, 2010, Pages 373-380

  Zhang, Hao ^a   Ran, Yuping ^a   Li, Dongming ^b   Liu, Yongfang ^c   Xiang, Yun ^a   Zhang, Ruifeng ^a   Dai, Yaling ^a  

^a SICHUAN UNIVERSITY   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

^c AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

Candida lusitaniae; Chaetomium atrobrunneum; Clavispora lusitaniae; Extracellular enzyme; Opportunistic fungi

Indexed keywords

FUNGAL RNA; RIBOSOMAL SPACER DNA; RIBOSOME RNA; RNA, RIBOSOMAL, 26S;

ARTICLE; BLEPHARITIS; CASE REPORT; CHAETOMIUM; DERMATOMYCOSIS; DIFFERENTIAL DIAGNOSIS; GENETICS; HUMAN; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; SACCHAROMYCETALES;

BLEPHARITIS; CHAETOMIUM; DERMATOMYCOSES; DIAGNOSIS, DIFFERENTIAL; DNA, RIBOSOMAL SPACER; HUMANS; INFANT; MALE; RNA, FUNGAL; RNA, RIBOSOMAL; SACCHAROMYCETALES;

BACTERIA (MICROORGANISMS); CHAETOMIUM; CHAETOMIUM ATROBRUNNEUM; CLAVISPORA LUSITANIAE; FUNGI;

EID: 77952668414     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-009-9266-9     Document Type: Article

References (35)

1. Rodrigues de Miranda L. Clavispora, a new yeast genus of the Saccharomycetales. Antonie van Leeuwenhoek. 1979; 45: 479-83.
2. Pappagianis D, Collins MS, Hector R, Remington J. Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother. 1979; 16: 123-6.
3. Dick JD, Merz WG, Saral R. Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother. 1980; 18: 158-63.
4. Hadfield TL, Smith MB, Winn RE, Rinaldi MG, Guerra C. Mycoses caused by Candida lusitaniae. Rev Infect Dis. 1987; 9: 1006-12.
5. Merz WG. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol. 1984; 20: 1194-5.
6. Merz WG, Sandford GR. Isolation and characterization of a polyene-resistant variant of Candida tropicalis. J Clin Microbiol. 1979; 9: 677-80.
7. Passarelli N, Miranda MP, Castro C. A study of the incidence of air-borne fungi in the city of Rio de Janeiro. Ann Allergy. 1949; 7: 334-8.
8. Guarro J, Soler L, Rinaldi MG. Pathogenicity and antifungal susceptibility of Chaetomium species. Eur J Clin Microbiol Infect Dis. 1995; 14: 613-8.
9. Abbott SP, Sigler L, McAleer R, et al. Fatal cerebral mycoses caused by the ascomycete Chaetomium strumarium. J Clin Microbiol. 1995; 33: 2692-8.
10. Barron MA, Sutton DA, Veve R, et al. Invasive mycotic infections caused by Chaetomium perlucidum, a new agent of cerebral phaeohyphomycosis. J Clin Microbiol. 2003; 41: 5302-7.
11. De Hoog GS, Guarro J, Gene′ J, Figueras MJ. Atlas of clinical fungi. 2nd ed. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands, Universitat Rovira i Virgili, Reus, Spain, 2000: 263-264.
12. Ran Y, He X, Zhang H, et al. Seborrheic dermatitis flare in a Dutch male due to commensal Malassezia furfur overgrowth. Med Mycol. 2008; 46: 611-4.
13. Zhang H, Ran Y, Liu Y, et al. Arthroderma vanbreuseghemii infection in three family members with kerion and tinea corporis. Med Mycol. 2009; 47: 539-44.
14. Vartivarian SE, Anaissie EJ, Bodey GP. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin Infect Dis. 1993; 17: S487-91.
15. Viudes A, Peman J, Canton E, et al. Two cases of fungemia due to Candida lusitaniae and a literature review. Eur J Clin Microbiol Infect Dis. 2002; 21: 294-9.
16. Blinkhorn RJ, Adelstein D, Spagnuolo PJ. Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol. 1989; 27: 236-40.
17. Nguyen MH, Morris AJ, Dobson ME, et al. Candida lusitaniae: an important emerging cause of candidemia. Infect Dis Clin Pract. 1996; 5: 273-8.
18. Ahearn DG, McGlohn MS. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole. J Clin Microbiol. 1984; 19: 412-6.
19. Krcmery VJ, Oravcova E, Spanic S, et al. Nosocomial breakthrough fungemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of etiology, risk factors, and outcome. J Antimicrob Chemother. 1998; 41: 373-80.
20. Cinar S, Nedret Koc A, Taskapan H, Dogukan A, Tokgoz B, Utas C. Case report: Candida lusitaniae peritonitis in a patient on continuous ambulatory peritoneal dialysis. Mycoses. 2002; 45: 120-2.
21. Nancy FC, Michael B. Candida lusitaniae meningitis. Infect Dis Clin Pract. 2007; 15: 359-63.
22. Yeghen T, Fenelon L, Campbell CK, et al. Chaetomium pneumonia in patient with acute myeloid leukaemia. J Clin Pathol. 1996; 49: 184-6.
23. Rinaldi MG, Inderlied CB, Mahnovski V, et al. Fatal Chaetomium atrobrunneum Ames, 1949, systemic mycosis in a patient with acute lymphoblastic leukemia, abstract PS2. 69. In: Abstracts of the XI congress of the international society for human and animal mycology. 1991. Montreal, p. 107.
24. Krcmery V Jr, Mateicka F, Grausova S, Kunova A, Hanzen J. Invasive infections due to Clavispora lusitaniae. FEMS Immunol Med Microbiol. 1999; 23: 75-8.
25. Sanchez PJ, Cooper BH. Candida lusitaniae: sepsis and meningitis in a neonate. Pediatr Infect Dis J. 1987; 6: 758-9.
26. Yinnon AM, Woodin KA, Powell KR. Candida lusitaniae infection in the newborn: case report and review of the literature. Pediatr Infect Dis J. 1992; 11: 878-80.
27. Hawkins JL, Baddour LM. Candida lusitaniae infections in the era of fluconazole availability. Clin Infect Dis. 2003; 36: e14-8.
28. Guppy KH, Thomas C, Thomas K, Anderson D. Cerebral fungal infections in the immunocompromised host: a literature review and a new pathogen-Chaetomium atrobrunneum: case report. Neurosurgery. 1998; 43: 1463-9.
29. Segal R, Kusne S. Cerebral fungal infections in the immunocompromised host: a literature review and a new pathogen-Chaetomium atrobrunneum: case report. Neurosurgery. 1999; 45: 200.
30. Thomas C, Mileusnic D, Carey RB, Kampert M, Anderson D. Fatal Chaetomium cerebritis in a bone marrow transplant patient. Hum Pathol. 1999; 30: 874-9.
31. Ryder NS, Wagner S, Leitner I. In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts. Antimicrob Agents Chemother. 1998; 42: 1057-61.
32. Anandi V, John TJ, Walter A, et al. Cerebral phaeohyphomycosis caused by Chaetomium globosum in a renal transplant recipient. J Clin Microbiol. 1989; 27: 2226-9.
33. Falcón CS, Falcón Mdel M, Ceballos JD, Florencio VD, Erchiga VC, Ortega SS. Onychomycosis by Chaetomium spp. Mycoses. 2009; 52: 77-9.
34. Serena C, Ortoneda M, Capilla J, et al. In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization. Antimicrob Agents Chemother. 2003; 47: 3161-4.
35. Smith MR, Ryu SH, Suh PG, Rhee SG, Kung HF. S-phase induction and transformation of quiescent NIH 3T3 cells by microinjection of phospholipase C. Proc Natl Acad Sci U S A. 1989; 86: 3659-63.